Corrigendum to “Neopetroside-B alleviates doxorubicin-induced cardiotoxicity via mitochondrial protection” [Biomed. Pharmacother. 165 (2023) 115232]

Corrigendum to “Neopetroside-B alleviates doxorubicin-induced cardiotoxicity via mitochondrial protection” [Biomed. Pharmacother. 165 (2023) 115232] Correction

Journal

Biomedicine & Pharmacotherapy
ISSN: 0753-3322 , E-ISSN: 1950-6007

Output data

Year: 2023, Volume: 169, Article number : 115933, Pages count : DOI: 10.1016/j.biopha.2023.115933

Authors

Yoon Chang Shin ¹ , Nifantiev Nikolay E. ² , Yashunsky Dmitry V. ² , Kim Hyoung Kyu ¹ , Han Jin ¹

Affiliations

1	Cardiovascular and Metabolic Disease Center, Smart Marine Therapeutics Center, Department of Physiology, College of Medicine, Inje University, Busan 47397, South Korea
2	Laboratory of Glycoconjugate Chemistry, N. D. Zelinsky Institute of Organic Chemistry, Russian Academy of Sciences, Moscow 119991, Russia

Yoon C.S. , Nifantiev N.E. , Yashunsky D.V. , Kim H.K. , Han J.
Corrigendum to “Neopetroside-B alleviates doxorubicin-induced cardiotoxicity via mitochondrial protection” [Biomed. Pharmacother. 165 (2023) 115232]
Biomedicine & Pharmacotherapy. 2023. V.169. 115933 . DOI: 10.1016/j.biopha.2023.115933 WOS Scopus OpenAlex

≡ Web of science:	WOS:001134037800001
≡ Scopus:	2-s2.0-85178401599
≡ OpenAlex:	W4388999252